Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
New Century Healthcare Holding Co. Limited (1518.HK)
HKD0.33
-0.02 (-4.35%)
CN HKSE Healthcare Medical - Care Facilities
Address
56 Nanlishi Road
Beijing, CN
Beijing, CN
CEO
Jason Zhou
Website
ncich.com.cn
IPO
2017-01-19
ISIN KYG6446R1020
Description
New Century Healthcare Holding Co. Limited functions as an investment enterprise, providing medical services specifically designed for women and children throughout the People's Republic of China. Its principal activities include specialized care in paediatrics, obstetrics, and gynaecology, complemented by hospital advisory services. Furthermore, the company offers digital healthcare solutions and operates on-site amenities like cafeterias and gift shops within its medical facilities. This entity was founded in 2002 and maintains its headquarters in Beijing, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
HKD0.33
-0.02 (-4.35%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
70.9K
Beta
0.04
Float Shares
233.71M
Free Float %
47.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.92% | -5.36% | -5.36% | -18.46% | -25.35% | -19.70% | -55.83% | +26.19% | -60.74% | -92.79% | -92.79% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.33
DCF (Unlevered)
1.86
+463.1%
DCF (Levered)
5.71
+1,629.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
67% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-0.92
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-29.1% Q4'25: -42.8% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%-344.7% Q4'25: -176.9% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-5.5% Q4'25: +3.1% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%-2.9% Q4'25: -3.7% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%-7.3% Q4'25: -18.4% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×50.70× ★ Q4'25: -25.37× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
490.93M
est: 467.55M (+5.0%)
|
536.46M
est: 552.95M (-3.0%)
|
615.98M
est: 570.69M (+7.9%)
|
729.37M
est: 696.58M (+4.7%)
|
512.79M
est: 841.69M (-39.1%)
|
632.57M
est: 949.67M (-33.4%)
|
636.46M
est: 1.03B (-38.1%)
|
933.07M
est: 1.04B (-10.1%)
|
846.50M
est: 1.19B (-29.0%)
|
600.10M
est: 588.72M (+1.9%)
|
588.72M
588.72M – 588.72M
+0.0% YoY
|
612.51M
612.51M – 612.51M
+4.0% YoY
|
710.34M
710.34M – 710.34M
+16.0% YoY
|
898.56M
898.56M – 898.56M
+26.5% YoY
|
1.05B
1.05B – 1.05B
+16.3% YoY
|
1.05B
1.05B – 1.05B
+0.7% YoY
|
| EBITDA |
196.90M
est: -22.07M (+992.1%)
|
178.23M
est: 158.21M (+12.7%)
|
157.67M
est: -26.94M (+685.3%)
|
174.65M
est: -32.88M (+631.1%)
|
-218.17M
est: 236.83M (-192.1%)
|
41.78M
est: -44.83M (+193.2%)
|
-209.54M
est: -48.57M (-331.5%)
|
234.18M
est: 346.39M (-32.4%)
|
170.68M
est: 46.71M (+265.4%)
|
3.28M
est: 22.95M (-85.7%)
|
22.95M
22.95M – 22.95M
+0.0% YoY
|
23.88M
23.88M – 23.88M
+4.0% YoY
|
27.69M
27.69M – 27.69M
+16.0% YoY
|
35.03M
35.03M – 35.03M
+26.5% YoY
|
40.75M
40.75M – 40.75M
+16.3% YoY
|
41.02M
41.02M – 41.02M
+0.7% YoY
|
| EBIT |
175.68M
est: -71.58M (+345.4%)
|
159.95M
est: 177.43M (-9.9%)
|
119.28M
est: -87.37M (+236.5%)
|
66.91M
est: -106.65M (+162.7%)
|
-312.96M
est: 265.60M (-217.8%)
|
-44.84M
est: -145.39M (+69.2%)
|
-279.79M
est: -157.51M (-77.6%)
|
174.20M
est: 388.47M (-55.2%)
|
142.74M
est: -44.07M (+423.9%)
|
-17.24M
est: -21.65M (+20.4%)
|
-21.65M
-21.65M – -21.65M
+0.0% YoY
|
-22.53M
-22.53M – -22.53M
-4.0% YoY
|
-26.13M
-26.13M – -26.13M
-16.0% YoY
|
-33.05M
-33.05M – -33.05M
-26.5% YoY
|
-38.45M
-38.45M – -38.45M
-16.3% YoY
|
-38.71M
-38.71M – -38.71M
-0.7% YoY
|
| Net Income |
98.64M
est: 62.82M (+57.0%)
|
114.89M
est: 99.99M (+14.9%)
|
73.44M
est: 69.17M (+6.2%)
|
4.49M
est: 57.13M (-92.1%)
|
-371.38M
est: 149.68M (-348.1%)
|
-101.46M
est: 29.52M (-443.7%)
|
-297.73M
est: 44.67M (-766.6%)
|
84.16M
est: 218.92M (-61.6%)
|
47.38M
est: 49.32M (-3.9%)
|
-115.31M
est: 114.62M (-200.6%)
|
114.62M
114.62M – 114.62M
+0.0% YoY
|
74.24M
74.24M – 74.24M
-35.2% YoY
|
58.26M
58.26M – 58.26M
-21.5% YoY
|
16.98M
16.98M – 16.98M
-70.9% YoY
|
32.49M
32.49M – 32.49M
+91.3% YoY
|
45.69M
45.69M – 45.69M
+40.6% YoY
|
| SGA |
121.32M
est: 132.30M (-8.3%)
|
100.51M
est: 118.46M (-15.2%)
|
145.08M
est: 161.48M (-10.2%)
|
190.83M
est: 197.10M (-3.2%)
|
167.34M
est: 177.32M (-5.6%)
|
217.24M
est: 268.72M (-19.2%)
|
194.11M
est: 291.10M (-33.3%)
|
198.15M
est: 259.36M (-23.6%)
|
192.73M
est: 334.62M (-42.4%)
|
184.73M
est: 164.40M (+12.4%)
|
164.40M
164.40M – 164.40M
+0.0% YoY
|
171.05M
171.05M – 171.05M
+4.0% YoY
|
198.37M
198.37M – 198.37M
+16.0% YoY
|
250.93M
250.93M – 250.93M
+26.5% YoY
|
291.91M
291.91M – 291.91M
+16.3% YoY
|
293.87M
293.87M – 293.87M
+0.7% YoY
|
| EPS |
0.35
est: 0.13 (+169.2%)
|
0.24
est: 0.22 (+7.7%)
|
0.15
est: 0.14 (+4.8%)
|
0.01
est: 0.12 (-92.1%)
|
-0.77
est: 0.03 (-2,439.1%)
|
-0.21
est: 0.06 (-443.7%)
|
-0.62
est: 0.09 (-770.7%)
|
0.17
est: 0.09 (+87.2%)
|
0.10
est: 0.10 (-3.4%)
|
-0.24
est: 0.24 (-201.2%)
|
0.24
0.24 – 0.24
+0.0% YoY
|
0.15
0.15 – 0.15
-35.2% YoY
|
0.12
0.12 – 0.12
-21.5% YoY
|
0.04
0.04 – 0.04
-70.9% YoY
|
0.07
0.07 – 0.07
+91.3% YoY
|
0.09
0.09 – 0.09
+40.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
68.05M
OE per share TTM
0.14
Owner's Yield
26.57%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
47.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-13.7K
Shares Outstanding
487.95M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jason Zhou | Executive Chairman & Chief Executive Officer | 3M | male |
| Han Xu | Chief Financial Officer, Senior Vice President & Executive Director | 3M | male |
| Hong Xin | Chief Operating Officer, Senior Vice President & Executive Director | 2M | female |
| Hong Zhou | Chief Physician, Group Chief Medical Officer & Vice President | — | female |
| Jingxin Zhang | Director of Strategic Investment & Vice President | — | female |
| Lan Teng | CEO of BNC Women's & Children's Hospital | — | female |
| Xiaofeng Jia | Vice President & Secretary | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1518.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
